Intex Retatrutide Prefilled Pen

Description

UNDERSTANDING RETATRUTIDE

Retatrutide is a medication which functions as a triple-hormone receptor agonist, targeting the GLP-1, GIP, and glucagon receptors. This unique mechanism aims to enhance satiety, improve glucose metabolism, and promote fat loss, used for obesity and metabolic disorder management.

Retatrutide is a synthetic peptide designed to activate three key hormonal pathways involved in metabolism:

1. GLP-1 (Glucagon-Like Peptide-1): Enhances insulin secretion, suppresses glucagon release, and promotes satiety.
2. GIP (Gastric Inhibitory Polypeptide): Stimulates insulin release and may influence fat storage.
3. Glucagon: Increases energy expenditure and promotes fat breakdown.

By targeting these receptors simultaneously, Retatrutide aims to provide a comprehensive approach to weight management and metabolic health.

BENEFITS:

1. Weight Loss

Retatrutide leads to significant weight reduction. Users experienced an average weight loss of up to 30.3%. This effect is dose-dependent, with higher doses yielding more substantial results.

2. Blood Sugar Control

Retatrutide has shown efficacy in improving glycemic control in individuals with type 2 diabetes. It has been associated with significant reductions in HbA1c levels, aiding in long-term blood sugar management.

3. Metabolic health

Beyond weight reduction, retatrutide is being used for broader metabolic effects. Clinical trials have reported improvements in measures including waist circumference, triglycerides, non-HDL cholesterol, systolic blood pressure and high-sensitivity C-reactive protein. The combination of significant weight loss and improvements in multiple metabolic markers makes retatrutide an important area of obesity and metabolic disease.

4. Cardiometabolic Health

Retatrutide has been shown to improve various cardiometabolic risk factors, including reductions in blood pressure, cholesterol levels, and fasting insulin. These benefits contribute to overall cardiovascular health.

ADMINISTRATION:

Use for subcutaneous injection only

DOSAGE RECOMMENDATION:

Week 1-4 | 2mg once a week

Week 5-8 | 4mg once a week

Week 9-12 | 8mg once a week

Week 13+ | 12mg once a week

(15 clicks – 1mg)